Abstract
This editorial reviews objective is to support the development of strategies to maximize the effectiveness of first-line and second-line antiretroviral therapy (ART) regimens and optimize the training of regimen switching in lower-income and middle-income countries (LMICs). The support is required to fully utilize the survival benefit of available treatment options maintain program cost-effectiveness and enable achievement of universal access to HIV treatment and states that the comprehensive strategy must be evidence based and focused on the rational long-term use of ART at a population level.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
